Skip to main content

Day: March 15, 2023

SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Net Asset Value of $7.39 Per Share as of December 31, 2022 NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) — SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2022. Net assets totaled approximately $210.0 million, or $7.39 per share, at December 31, 2022 as compared to $7.83 per share at September 30, 2022 and $11.72 per share at December 31, 2021. “Over the weekend, the second and third largest bank failures in U.S. history occurred. The residual impact of these events is still rippling through the broader markets. Our team was quick to assess and, where possible, mitigate exposure to affected banks and to support our portfolio companies, as needed. SuRo Capital’s direct exposure to affected banks was...

Continue reading

Five Below, Inc. Announces Fourth Quarter and Fiscal 2022 Financial Results

Q4 Net Sales Increase of 13%; Q4 Comparable Sales Increase of 1.9%   Q4 EPS Increase of 23% to $3.07 PHILADELPHIA, March 15, 2023 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE) today announced financial results for the fourth quarter and full year of fiscal 2022 ended January 28, 2023 and outlook for fiscal 2023. For the fourth quarter ended January 28, 2023:Net sales increased by 12.7% to $1,122.8 million from $996.3 million in the fourth quarter of fiscal 2021; comparable sales increased by 1.9% versus the fourth quarter of fiscal 2021. The Company opened 48 new stores and ended the quarter with 1,340 stores in 42 states. This represents an increase in stores of 12.6% from the end of the fourth quarter of fiscal 2021. Operating income was $225.8 million compared to $187.6 million in the fourth quarter of fiscal 2021. The...

Continue reading

MacroGenics Provides Corporate Update and 2022 Financial Results

Cash runway extended through 2025 with $250 million in non-dilutive funding over past eight months TAMARACK study design modified with objective of accelerating data readout Encouraging lorigerlimab (PD-1 × CTLA-4 bispecific DART® molecule) monotherapy clinical data presented at ASCO-GU Conference call scheduled for today at 4:30 p.m. ETROCKVILLE, Md., March 15, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the year ended December 31, 2022. “Our recent presentation of encouraging, preliminary lorigerlimab data in patients with metastatic castration-resistant prostate cancer (mCRPC) at...

Continue reading

Capricor Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

-Enrollment Continues to Progress in HOPE-3, the Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy (DMD); Plan to Report on Interim Analysis in Q4 2023- -Held Type-B CMC Meeting with U.S. Food and Drug Administration (FDA) Regarding Pathway Towards Biologics License Application (BLA) for CAP-1002 in DMD- -Expanded Partnership with Nippon Shinyaku to Japan to Leverage Commercial DMD Franchise with $12 Million Upfront and Additional Potential Milestone Payments of up to $89 Million- -To Host Conference Call and Webcast Today at 4:30 p.m. ET- SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today...

Continue reading

Vaxart Provides Business Update and Full Year 2022 Financial Results

Prioritizing oral bivalent norovirus candidate, one of the most advanced norovirus vaccines in development Will continue preclinical development of novel COVID-19 vaccine constructs to enhance cross-reactivity and potency with the goal of developing a pan-betacoronavirus vaccine Portfolio prioritization extends cash runway into Q2 2024 Conference call today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Vaxart, Inc. (NASDAQ: VXRT) issued its business update today for the full year 2022, during which Vaxart announced it is prioritizing development of the Company’s bivalent norovirus candidate. “After completing six norovirus clinical trials, we are encouraged by the robust immunogenicity data in both young adult and elderly populations and the encouraging safety profile of our oral norovirus program....

Continue reading

Patriot Battery Metals Announces C$50M Flow-Through Financing

Not for Distribution to U.S. News Wire Services or for Dissemination in the U.S. HighlightsC$50 million raise to accelerate critical mineral exploration on Corvette PropertyPrivate placement of flow through shares conducted at price of C$22.57 representing a 90% premium to the Company’s last traded share price on TSX-V as of Monday, 13 March 2023Strong demand from existing and new institutional, professional and sophisticated investorsPlacement completed via issuing of CDI’s increasing the liquidity on the ASXProceeds will be used to accelerate exploration on the Corvette Lithium Project Initial mineral resource for CV5 targeted for the June 2023Blair Way, the Company’s President, CEO, & Director, comments: “The Corvette Property is shaping up as an extraordinary discovery and the strong support shown for this capital...

Continue reading

Nokia Corporation: Repurchase of own shares on 15.03.2023

Nokia CorporationStock Exchange Release15 March 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 15.03.2023 Espoo, Finland – On 15 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 319,371 4.28CEUX 3,855 4.25AQEU 786 4.37TQEX 1,088 4.28Total 325,100 4.28* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

MBG Holdings Secures Contract to Design and Build Cellular and Fiber Networks for TechFort, a New Tech Hub in the U.K.

AUSTIN, TX, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – MBG Holdings, Inc (OTC Pink: MBGH), holding company of Onepath systems and AMR Resources, LLC, a leading telecommunications lifecycle company, secured a contract to design, build and deploy the cellular and fiber networks for TechFort, a large-scale, much-anticipated development in Dover, England, UK. MBG has the sole rights to develop the fiber, the conduit, neutral host cellular, and private 5G cellular for the 40-acre campus with office space, multifamily homes, entertainment venues, and more. Situated on the British coast overlooking the port of Dover, TechFort is an ambitious construction and renovation project that repurposes the famous Western Heights, a series of Napoleon-era fortresses, into an advanced technology hub. MBG will develop and operate a neutral-host...

Continue reading

Noranda Income Fund Announces Completion of Acquisition by Glencore

TORONTO, March 15, 2023 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX: NIF.UN) (the “Fund”) today announced that the previously announced acquisition by Glencore Canada Corporation (“Glencore”) of all of the issued and outstanding priority units of the Fund for C$1.98 per priority unit by way of a plan of arrangement under the Business Corporations Act (Ontario) and the Trustee Act (Ontario) (the “Arrangement”) was completed. Immediately prior to the Arrangement, Glencore owned 12,500,000 special units of the Fund representing approximately 25% of the 49,989,975 issued and outstanding units of the Fund. As a result of the Arrangement, Glencore acquired all of the 37,489,975 issued and outstanding priority units of the Fund. Following completion of the Arrangement, Glencore owns 100% of the issued and outstanding units of the Fund. Computershare...

Continue reading

Todos Medical Supports Long COVID Awareness Day

NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced its support for International Long COVID Awareness Day.  Todos Medical is fully aligned with the Long COVID community and its effort to boost awareness, as well as calls for additional resources to be invested to fight this potentially debilitating condition. Social media platforms around the world are hosting special online events, highlighting the impact this disease has had on everyday living.  The hashtags #LongCovid and #LongCovidAwarenessDay are being circulated to facilitate much needed dialogue on the topic. “There are tens of millions of people affected by Long COVID syndrome, post-acute sequelae of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.